Management of resistance to lymphoblastoid interferon alpha in chronic myeloid leukaemia

Br J Haematol. 1998 Dec;103(4):1208-9. doi: 10.1046/j.1365-2141.1998.1161c.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Drug Resistance
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Male
  • Middle Aged
  • Recombinant Proteins

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins